PM
RETA
Prosight Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,112
| Closed | -$1.5M | – | 50 |
|
|
2020
Q4 | $1.5M | Sell |
12,112
-102,442
| -89% | -$12.7M | 0.69% | 26 |
|
|
2020
Q3 | $11.2M | Buy |
114,554
+32,454
| +40% | +$3.16M | 5.31% | 4 |
|
|
2020
Q2 | $12.8M | Buy |
82,100
+7,100
| +9% | +$1.11M | 5.5% | 2 |
|
|
2020
Q1 | $10.8M | Buy |
75,000
+12,100
| +19% | +$1.75M | 5.06% | 6 |
|
|
2019
Q4 | $12.9M | Buy |
62,900
+309
| +0.5% | +$63.2K | 5.65% | 6 |
|
|
2019
Q3 | $5.03M | Sell |
62,591
-62,374
| -50% | -$5.01M | 2.79% | 16 |
|
|
2019
Q2 | $11.8M | Sell |
124,965
-50,735
| -29% | -$4.79M | 5.94% | 4 |
|
|
2019
Q1 | $15M | Sell |
175,700
-77,300
| -31% | -$6.61M | 6.57% | 4 |
|
|
2018
Q4 | $14.2M | Buy |
253,000
+172,845
| +216% | +$9.7M | 7.33% | 2 |
|
|
2018
Q3 | $6.55M | Sell |
80,155
-2,939
| -4% | -$240K | 3.65% | 10 |
|
|
2018
Q2 | $2.91M | Sell |
83,094
-214,656
| -72% | -$7.51M | 2.13% | 18 |
|
|
2018
Q1 | $6.11M | Buy |
297,750
+124,853
| +72% | +$2.56M | 3.83% | 8 |
|
|
2017
Q4 | $4.9M | Buy |
+172,897
| New | +$4.9M | 3.6% | 11 |
|